Abris Capital Partners has signed a deal to acquire Polish healthcare network operator Scanmed from South African healthcare provider Life Healthcare Group for PLN340 million ($90.72 million).

The private equity investor, which is focused on Central Europe, is acquiring the Polish healthcare business through its Abris CEE Mid-Market III LP fund.

Scanmed operates in 42 locations in Poland that offer primary healthcare and specialist consultations, advanced diagnostics, and also hospital treatment. Life Healthcare Group is selling the Polish healthcare business for reducing its debt.

Abris Capital Partners plans to support the Polish healthcare network in extending its service offering and geographic coverage, and also in the continued enhancement of its medical facilities and care in key therapeutic areas.

Scanmed will also look to boost commercial revenues in orthopedics, rehabilitation, ophthalmology, and urogynecology, and for opening new labs and surgery units.

Currently, the Polish healthcare network operates a couple of multi-specialist hospitals, 13 cardiac centers for providing diagnostics and cardiological treatment, and a range of clinics and medical centers across the country.

Scanmed also offers outpatient care services in major Polish cities such as Warsaw, Kraków, Wroclaw, Poznan, Gdansk and Pabianice.

Wojciech Łukawski – Partner at Abris Capital Partners said: “We look forward to working hand in hand with Scanmed’s experienced management team and first-class medical personnel – the key asset of the group – in establishing the company as an institution of choice for Polish patients.

“We are also privileged to partner with a company that has provided such vital support in tackling the Covid-19 pandemic in Poland, in cooperation with public healthcare institutions.”

The previous investments made by Abris Capital Partners in the healthcare sector include ITP, a Polish vendor of aesthetic medicine products, and Dentotal Protect – a distributor of dental consumables, instruments, and equipment in Romania.

The deal, which is subject to regulatory approvals, is likely to close in Q1 2021.

  Abris Capital Partners, Life Healthcare, Life Healthcare Group, Scanmed, Wojciech Łukawski